Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | 13.28% | $ 8.23M | $ 61.95M |
3/31/2025 | 7.74% | $ 4.63M | $ 59.76M |
12/31/2024 | 7.34% | $ 3.92M | $ 53.4M |
9/30/2024 | -19.5% | $ -8.91M | $ 45.67M |
6/30/2024 | -38.85% | $ -14.79M | $ 38.05M |
3/31/2024 | 13.52% | $ 8.06M | $ 59.65M |
12/31/2023 | 15.97% | $ 10.46M | $ 65.49M |
9/30/2023 | 21.34% | $ 13.58M | $ 63.63M |
6/30/2023 | 18.29% | $ 12.34M | $ 67.46M |
3/31/2023 | -33.06% | $ -13.6M | $ 41.14M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: Op. Inc. [ $ 2.07M ] / Revenues [ $ 61.16M ]
(=) Operating % [ 3.39% ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |